Publication | Closed Access

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial

HepatologyHepatitis CViral HepatitisLiver PhysiologyMulticentre Phase 3Compensated CirrhosisAntiviral TherapyHepatitisVirologyComplications Of CirrhosisLiver DiseaseChronic Viral InfectionMedicineEpidemiology